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Editor in Chief1 
Indicators which help us evaluate the burden 
of a disease and its related health interventions 
include financial cost, mortality, and 
morbidity.1 Quality-adjusted life year (QALY) 
and disability-adjusted life year (DALY) are 
two indicators that quantify the total number 
of years lost because of illness.2 One DALY is 
equal to one year of healthy life lost, and 
disease burden is a measure of the gap 
between current health status and the ideal 
health status.3 These indicators help us 
compare disease burdens, and have also been 
used to forecast the possible impacts of health 
interventions.3  
However, as a limitation, DALY is a 
generalization of a multifaceted reality, and 
consequently, provides a rough indication of 
health impact.4 The consideration of only 
DALY is not enough for policy makers to base 
health care plans upon. Policy makers pay the 
greatest attention to the highest DALYs; 
however, the presence of lower DALYs, as the 
major contributing factors of disease burden, 
should not be ignored. For instance, maternal 
death maintains a high disease burden, and 
prevention of coughs in infants does not 
receive enough financial support.4  




The Iranian healthcare system is effective in 
countering temporary problems, like treating 
infections. However, a chronic disease should 
be considered as an epidemic, and as the 
population ages, health care policy makers 
should be more efficient in countering chronic 
diseases. Chronic conditions, like 
malignancies, heart disease, lung disease, and 
diabetes, have the highest cost for the health 
care system.4  
In Iran’s health care system, chronic 
diseases obtain less attention compared to 
infectious diseases.5 A complete action plan 
should begin with a comprehensive study and 
end in a multifaceted intervention, linking the 
whole health system in Iran.5 Iran has a well-
built primary health care system that has been 
very efficient in decreasing the burden of 
infectious diseases, infant mortality, and 
maternal mortality, and increasing the well-
being of mother and child. However, this 
system is not intended to reduce the burden of 
chronic diseases.6,7 
Chronic diseases affect national economies 
in a negative way. Medical charges drain 
investments in economic fields which in turn 
worsen the national economy.8 The direct costs 
of chronic diseases are huge and their 
estimates vary in different regions or years. 
This may cause inequality in access to 
healthcare benefits, investment systems, and 
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other related issues.8 Evidently, health 
expenditures are services that are used to 
prevent disease.9 
In Iran and other countries, chronic diseases 
are responsible for the majority of mortalities 
and morbidities. This issue is the major 
causative factor in failures in economic 
development. Therefore, interventions should 
be made in a comprehensive way to reach the 
global goal of chronic diseases prevention in 
order to reduce the burden of disease and its 
related financial costs. 
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